Filing Details
- Accession Number:
- 0001487371-20-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-23 18:39:18
- Reporting Period:
- 2020-01-23
- Accepted Time:
- 2020-01-23 18:39:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1487371 | Genmark Diagnostics Inc. | GNMK | Surgical & Medical Instruments & Apparatus (3841) | 272053069 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1543884 | Michael Gleeson | 5964 La Place Court Carlsbad CA 92008 | Svp, Corp. Accounts | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-23 | 11,563 | $0.00 | 340,980 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-01-23 | 4,988 | $4.93 | 335,992 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Market Stock Units | Acquisiton | 2020-01-23 | 5,347 | $0.00 | 5,347 | $0.00 |
| Common Stock | Market Stock Units | Acquisiton | 2020-01-23 | 6,216 | $0.00 | 6,216 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,305 | No | 4 | M | Direct | ||
| 18,784 | No | 4 | M | Direct |
Footnotes
- The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted market stock units.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $4.80 to $5.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index.
- The MSUs vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index.
Billionaire Hedge Funds
